Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population?
Marijn M. Speeckaert(Ghent University Hospital), Hakan Nacak, James Heaf(Zealand University Hospital), Johan De Sutter(Ghent University Hospital), Luigi Gnudi(Harvard University), Ionuţ Nistor(Grigore T. Popa University of Medicine and Pharmacy), Luís Coentrão, Andrzej Więcek(Medical University of Silesia), Olof Heimbürger(Karolinska University Hospital), Steven Van Laecke(Ghent University Hospital), Kitty J. Jager(Amsterdam University Medical Centers), Davide Bolignano(Istituto di Fisiologia Clinica), David Goldsmith(University College London), Christiane Drechsler(Universitätsklinikum Würzburg), Wim Van Biesen(Ghent University Hospital), Adrian Covic, R. Vanholder(Ghent University Hospital), Laurent Weekers, María José Soler(Mayo Clinic), Robbert J. Slingerland(Isala), Cécile Couchoud(Agence de la Biomédecine), Henk J.G. Bilo(University Medical Center Groningen), Charles Tomson(Freeman Hospital), J. Delanghe(Ghent University Hospital), L. Vanhuffel(Ghent University Hospital), Wim Van Biesen(Ghent University Hospital)
Cited by 115
Related Papers
Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure
|Kidney International|1999|1.8k
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis
|The Lancet|2012|1.4k
Clinical practice guideline on diagnosis and treatment of hyponatraemia
|Intensive Care Medicine|2014|1k
IL-10, IL-6, and TNF-α: Central factors in the altered cytokine network of uremia—The good, the bad, and the ugly
|Kidney International|2005|927
A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
|Kidney International|2019|886